Dr Martha Gulati (Head of Cardiology, University of Arizona College of Medicine, Phoenix, AZ, USA) discusses the subject of women and cardiovascular disease, the difference between sex and gender and how both sex and gender can affect diagnosis and treatment of cardiovascular disease.
Filmed at ESC 2018, Munich.
View more content here.
Speaker Disclosure: Dr Martha Gulati has nothing to disclose in relation to this video interview.
1. How has our understanding of the role of gender in cardiovascular disease changed over the last few decades?
2. What differences are there between men and women in terms of risk factors for cardiovascular disease? (0:08)
3. Are there any gender differences in treatment responses and outcomes? (3:22)
4. Please describe any ongoing projects and programs there are to better understand and treat cardiovascular disease in women? (0:08)
touchCARDIO.com is an independent information resource supporting physicians, clinicians and leading industry professionals in continuously developing their knowledge, effectiveness and productivity, via open-access content in multimedia formats.
Share this Video
Related Videos In Cardiovascular Disease
Zsolt Piroth, TCT 2022: The value of post-PCI FFR and intravascular imaging for cardiovascular failure, a FAME 3 substudy
This FAME 3 substudy aimed to define the value of post-percutaneous coronary intervention (PCI) fractional flow reserve (FFR) and intravascular imaging for cardiovascular failure. In this touchCARDIO interview, we speak with Dr Zsolt Piroth (Gottsegen National Cardiovascular Institute, Budapest, Hungary) to discuss the substudy of the FAME 3 trial and the implications for clinical practice. […]
Zsolt Piroth, TCT 2022: The value of measuring post-PCI FFR in patients with coronary artery disease
The impact of post-percutaneous coronary intervention (PCI) fractional flow reserve (FFR) has been assessed in patients with coronary artery disease (CAD). In this touchCARDIO interview, we speak with Dr Zsolt Piroth (Gottsegen National Cardiovascular Institute, Budapest, Hungary) to discuss the prognostic value for measuring post-PCI FFR and intravascular imaging in CAD. Click here for part […]
Divaka Perera, ESC 2022: Percutaneous revascularisation in patients with severe ischaemic cardiomyopathy, the REVIVED trial
The REVIVED study aimed to assess whether the addition of stents when treating patients with severe ischaemic cardiomyopathy would be beneficial to patient outcomes. In this touchCARDIO interview, we speak with Professor Divaka Perera (King’s College London, London, UK) to discuss the REVIVED trial, its outcomes and how they will affect the current treatment paradigm. […]
Journal articles and more to your inbox
Get the latest clinical insights from touchCARDIOSign me up!